Colin Hill
Live online courses, books, and videos on O’Reilly
Bio
Colin Hill is the president, chairman and co-founder of GNS
Healthcare. He brings years of hands-on scientific experience to his
role, with expertise in the areas of computational physics and systems
biology.
Colin is a frequent speaker at international scientific and industry
conferences and has appeared in numerous publications and television
segments including The Wall Street Journal, CNBC Morning Call, Nature,
Forbes, Wired, and The Economist. He serves as CEO and Chairman of GNS
Healthcare's parent company Via Science, and chairman of the board of
Fina Technologies, a subsidiary of Via Science that applies
next-generation artificial intelligence technology to real-time
financial trading. He also serves on the board of directors of AesRx,
a biopharmaceutical company dedicated to the development of a new
treatment for sickle cell disease.
In 2004, Colin was named to MIT Technology Review's TR100 list of the
top innovators in the world under the age of 35. He graduated from
Virginia Tech with a degree in physics and earned master's degrees in
physics from McGill University and Cornell University.